BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30671343)

  • 1. High prevalence of fasciolosis and evaluation of the efficacy of anthelmintics against
    Zhang JL; Si HF; Zhou XZ; Shang XF; Li B; Zhang JY
    Int J Parasitol Parasites Wildl; 2019 Apr; 8():82-87. PubMed ID: 30671343
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluating the effectiveness of trematocides against Fasciola gigantica and amphistomes infections in cattle, using faecal egg count reduction tests in Iringa Rural and Arumeru Districts, Tanzania.
    Nzalawahe J; Hannah R; Kassuku AA; Stothard JR; Coles G; Eisler MC
    Parasit Vectors; 2018 Jul; 11(1):384. PubMed ID: 29970147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of fasciolosis and evaluation of drug efficacy against Fasciola hepatica in dairy cattle in the Maffra and Bairnsdale districts of Gippsland, Victoria, Australia.
    Elliott TP; Kelley JM; Rawlin G; Spithill TW
    Vet Parasitol; 2015 Apr; 209(1-2):117-24. PubMed ID: 25771931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of flukicides against Fasciola hepatica and first report of triclabendazole resistance on German sheep farms.
    Kahl A; von Samson-Himmelstjerna G; Helm C; Hodgkinson J; Williams D; Weiher W; Terhalle W; Steuber S; Ganter M; Krücken J
    Int J Parasitol Drugs Drug Resist; 2023 Dec; 23():94-105. PubMed ID: 38006779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparative efficacy of four anthelmintics against a natural acquired Fasciola hepatica infection in hill sheep flock in the west of Ireland.
    Mooney L; Good B; Hanrahan JP; Mulcahy G; de Waal T
    Vet Parasitol; 2009 Oct; 164(2-4):201-5. PubMed ID: 19556063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of efficacy of triclabendazole against Fasciola hepatica is present on sheep farms in three regions of England, and Wales.
    Kamaludeen J; Graham-Brown J; Stephens N; Miller J; Howell A; Beesley NJ; Hodgkinson J; Learmount J; Williams D
    Vet Rec; 2019 Apr; 184(16):502. PubMed ID: 30824600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point prevalence of bovine fascioliasis and the influence of chemotherapy on the milk yield in a lactating bovine population from the district of Toba Tek Singh, Pakistan.
    Khan MK; Sajid MS; Khan MN; Iqbal Z; Arshad M; Hussain A
    J Helminthol; 2011 Sep; 85(3):334-8. PubMed ID: 21062526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fasciola hepatica: a comparative survey of adult fluke resistance to triclabendazole, nitroxynil and closantel on selected upland and lowland sheep farms in Northern Ireland using faecal egg counting, coproantigen ELISA testing and fluke histology.
    Hanna RE; McMahon C; Ellison S; Edgar HW; Kajugu PE; Gordon A; Irwin D; Barley JP; Malone FE; Brennan GP; Fairweather I
    Vet Parasitol; 2015 Jan; 207(1-2):34-43. PubMed ID: 25529143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of an injectable combination anthelmintic (nitroxynil+clorsulon+ivermectin) against early immature Fasciola hepatica compared to triclabendazole combination flukicides given orally or topically to cattle.
    Hutchinson GW; Dawson K; Fitzgibbon CC; Martin PJ
    Vet Parasitol; 2009 Jun; 162(3-4):278-84. PubMed ID: 19375232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing an in vivo egg reduction test and in vitro egg hatching assay for different anthelmintics against Fasciola species, in cattle.
    Arafa WM; Shokeir KM; Khateib AM
    Vet Parasitol; 2015 Nov; 214(1-2):152-8. PubMed ID: 26455573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a commercially available enzyme-linked immunosorbent assay for detecting antibodies to Fasciola hepatica and Fasciola gigantica in cattle, sheep and buffaloes in Australia.
    Molloy JB; Anderson GR; Fletcher TI; Landmann J; Knight BC
    Vet Parasitol; 2005 Jun; 130(3-4):207-12. PubMed ID: 15925723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental infection of rabbits with Fasciola gigantica and treatment with triclabendazole (TCBZ) or BT6: parasitological, haematological and immunological findings.
    Sherif N; Shalaby I; Abdel Moneim M; Soliman M
    J Egypt Public Health Assoc; 2001; 76(5-6):505-29. PubMed ID: 17216940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative efficacy of anthelmintics and their effects on hemato-biochemical changes in fasciolosis of goats of South Gujarat.
    Shrimali RG; Patel MD; Patel RM
    Vet World; 2016 May; 9(5):524-9. PubMed ID: 27284231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First report of closantel treatment failure against Fasciola hepatica in cattle.
    Novobilský A; Höglund J
    Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):172-7. PubMed ID: 26448903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of the prevalence and intensity of Fasciola hepatica infection in dairy cattle from six irrigation regions of Victoria, South-eastern Australia, further identifying significant triclabendazole resistance on three properties.
    Kelley JM; Rathinasamy V; Elliott TP; Rawlin G; Beddoe T; Stevenson MA; Spithill TW
    Vet Parasitol; 2020 Jan; 277():109019. PubMed ID: 31918044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular identification and seasonal infections of species of Fasciola in ruminants from two provinces in China.
    Yuan W; Liu JM; Lu K; Li H; Duan MM; Feng JT; Hong Y; Liu YP; Zhou Y; Tong LB; Lu J; Zhu CG; Jin YM; Cheng GF; Lin JJ
    J Helminthol; 2016 May; 90(3):359-63. PubMed ID: 26123576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative kinetics of serological and coproantigen ELISA and faecal egg count in cattle experimentally infected with Fasciola hepatica and following treatment with triclabendazole.
    Brockwell YM; Spithill TW; Anderson GR; Grillo V; Sangster NC
    Vet Parasitol; 2013 Sep; 196(3-4):417-26. PubMed ID: 23643623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of Fasciola hepatica against Triclabendazole in cattle in Cajamarca (Peru): a clinical trial and an in vivo efficacy test in sheep.
    Ortiz P; Scarcella S; Cerna C; Rosales C; Cabrera M; Guzmán M; Lamenza P; Solana H
    Vet Parasitol; 2013 Jul; 195(1-2):118-21. PubMed ID: 23352107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host responses during experimental infection with Fasciola gigantica or Fasciola hepatica in Merino sheep I. Comparative immunological and plasma biochemical changes during early infection.
    Raadsma HW; Kingsford NM; Suharyanta ; Spithill TW; Piedrafita D
    Vet Parasitol; 2007 Feb; 143(3-4):275-86. PubMed ID: 17069976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardisation of a coproantigen reduction test (CRT) protocol for the diagnosis of resistance to triclabendazole in Fasciola hepatica.
    Flanagan AM; Edgar HW; Forster F; Gordon A; Hanna RE; McCoy M; Brennan GP; Fairweather I
    Vet Parasitol; 2011 Feb; 176(1):34-42. PubMed ID: 21093156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.